Tisotumab vedotin
HealthData.Gov
Updated Jun 12, 2026
About this dataset
Tivdak (tisotumab vedotin) is a prescription biologic drug manufactured by Seagen Inc., approved under BLA 761208. It's an injectable powder for intravenous solution, available in 40 mg vials, used to treat certain cancers. Marketed since September 2021. This information was generated using AI and is provided for informational and research purposes only.
Data and resources (1)
- HTML
Tisotumab vedotin
Access the FDA dataset for Tisotumab vedotin — ANDA 203308 submitted by Mylan Institutional LLC
Modified Dec 27, 2025